GSK872: Mechanism of Action

GSK872 MOA:Targeting RIPK3/Necroptosis Pathway for Neurodegenerative Diseases

🎯 check GSK872 product page

GSK872 is a specific RIPK3 inhibitor. It affects MAPK and NF-kB signaling by blocking RIPK3 activation to inhibit necroptosis.

Primary Applications and Mechanism of Action